The global dry mouth relief market size is expected to reach USD 3.12 Billion by 2030 at a CAGR of 4.4%, according to the latest report by Reports and Data. Growth of this market is majorly driven by rising incidence of dry mouth and associated diseases such as Sjogren’s syndrome, growing awareness about the causes of dry mouth, increasing side-effects of chemotherapy and radiotherapy, and surging prevalence among the geriatric population. Rising demand for mouthwashes, sugar-free chewing gums, saliva substitute gels, and lozenges indicated for dry mouth has positively influenced market growth. Moreover, increasing consumption of caffeinated and alcoholic beverages that cause dehydration is another major factor propelling market growth.
Dry mouth, also called xerostomia or hyposalivation, is a condition characterized by dryness in the mouth due to inadequate functioning of the salivary glands. Insufficient saliva secretion, dry feeling in the mouth, frequent thirst, and bad breath are some of the common symptoms of this condition. Dehydration is one of the most common factors that cause dry mouth. However, dry mouth often occurs as a side-effect of medications including anti-hypertensives, anti-depressants, anti-psychotics, antispasmodics, and sedatives. Pilocarpine (Salagen), cevimeline (Evoxac), amifostine (Ethyol), and various saliva substitutes or stimulants such as Aquoral, Caphosol, and NeutraSal are among the commonly prescribed drugs for dry mouth that stimulate saliva secretion. There are also many home remedies that provide relief from dry mouth. Improved oral care, increased water intake, and avoiding caffeine and alcohol that lead to dehydration are some effective ways to fight this condition.
Global Dry Mouth Relief Market: Dynamics
Drivers: Increasing cases of dry mouth caused by drug side-effects
Growing incidences of dry mouth caused by side-effects of certain drugs and medical treatments are expected to boost the global dry mouth relief market growth. Growing use of drugs such as anti-depressants, anti-hypertensives, anti-psychotics, antispasmodics, and decongestants, increasing side-effects of medical conditions such as Sjögren’s syndrome, Alzheimer's disease, and Parkinson's disease, and adverse effects of chemotherapy and other radiation therapies on saliva production have led to higher demand for dry mouth medications.
Restraints: Side-effects associated with artificial saliva substitutes
Growing awareness about the side-effects associated with artificial saliva substitutes is a key factor restraining global market growth. Some of the most common side-effects of using artificial saliva products are altered speech, lack of taste, difficulty in chewing and swallowing, swelling of lips or tongue, troubled breathing, allergic reactions like rash, and digestive problems.
Global Dry Mouth Relief Market: Drug Type Outlook
The over-the-counter segment is the fastest-growing segment in terms of revenue. Surging demand for over-the-counter drugs for dry mouth such as mouthwashes, saliva substitute gels, lozenges, and toothpastes, owing to their easier availability and higher cost-effectiveness as compared to prescription drugs, is a key factor driving this segment’s growth.
Global Dry Mouth Relief Market: Regional Outlook
Among regional markets, North America is the most dominant in terms of revenue. Market growth in this region is driven by growing prevalence of xerostomia and associated diseases such as Sjogren’s syndrome and HIV/AIDS, expanding geriatric population, increasing habits of smoking and alcohol consumption, mainly among the youth, and surging use of drugs such as anti-hypertensives and anti-depressants.
Companies Profiled in the Report:
Mission Pharmacal Company, GlaxoSmithKline Plc, Prestige Consumer Healthcare Inc., Colgate-Palmolive Company, Sanofi S.A., Mars, Incorporated, Bioxtra, Sunstar Group, Fresenius Medical Care AG & Co. KGaA, Dr. Fresh Inc., Xlear Inc., Johnson & Johnson Services Inc., Oral BioTech LLC, TheraBreath, The 3M Company, Wisconsin Pharmacal Company LLC, and The Procter & Gamble Company are among the top companies in the global dry mouth relief market.
Report Scope & Segments Covered in the Report:
This report offers historical data points and forecasts and revenue growth at a global, regional, and country level, and provides analysis, industry trends, and consumption pattern details for each region, major country, and segment from 2022 to 2030. The global dry mouth relief market report includes industry trends, drivers, restraints, opportunities, threats, market strategies, segment revenue, and market share contribution by each regional and country market. In addition, the report offers industry analysis and competitive landscape, company financials, and impact analysis. The report includes a detailed view of the global dry mouth relief market, along with changing dynamics and trends, scenarios, detailed market and regional segmentation, regional landscape, analysis and evaluation, major investments, product offerings, product launches, and details of historical, current, and projected revenues.
For the purpose of this report, the global dry mouth relief market is segmented based on drug type, product type, distribution channel, and region:
Drug Type Outlook (Revenue, USD Billion; 2022-2030)
Product Type Outlook (Revenue, USD Billion; 2022-2030)
Distribution Channel Outlook (Revenue, USD Billion; 2022-2030)
Region Outlook (Revenue, USD Billion; 2022-2030)